At Global Patients we are launching a new study for Type-2 diabetes patients taking Rybelsus in the UK. The purpose of the research is to understand the experiences patients have had whilst taking Rybelsus. Participants will conduct a 15min pre-task from home through an online platform.
In appreciation for your time and insight, you will receive a 60GBP incentive. If you are interested in this study, please contact firstname.lastname@example.org